NGM Biopharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for the treatment of serious diseases. The company leverages its biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable it to move rapidly into proof-of-concept studies and deliver potential first-in-class medicines to patients. NGM aspires to operate one of the most productive research and development engines in the biopharmaceutical industry, with multiple programs in clinical development.